ARTICLE | Clinical News
Asfotase alfa regulatory update
April 28, 2014 7:00 AM UTC
Alexion disclosed in its 1Q14 earnings that it began submission of a rolling BLA to FDA for asfotase alfa to treat hypophosphatasia (HPP) - an inherited metabolic disease characterized by defective bo...